Potential of adenovirus as a vector for sustained gene expression

Inder Verma received his Ph.D. in biochemistry from the Weizmann Institute of Science, Rehovot, Israel, in 1971, and was a postdoctoral fellow (with David Baltimore) in the Department of Biology, Massachussetts Institute of Technology. He is currently American Cancer Society Professor of Molecular Biology, Chair of the Laboratory of Genetics at the Salk Institute for Biological Studies, and Adjunct Professor in the Department of Biology, University of California at San Diego. Inder Verma is a member of the National Academy of Sciences (USA). He is a member of the editorial boards of The Journal of Gene Medicine, Journal of Virology and Gene, and serves on several other scientific advisory boards. His major fields of interest are molecular analysis of oncoproteins, and suppressor genes, gene therapy involving retroviral, adenoviral, AAV vectors, and generation of novel lentiviral vectors. Copyright © 1999 John Wiley & Sons, Ltd.